HS North America Ltd. /
Aptose
HS North America Ltd. agrees to buy Aptose
Source for the buyer and target: Aptose Biosciences Inc.
For the buyer and target.
“On November 18, 2025, Aptose entered into an Arrangement Agreement with Hanmi Pharmaceutical Co. Ltd (the “Parent”) and HS North America Ltd. (the “Purchaser”), a wholly-owned subsidiary of the Parent, which was then amended and restated by the parties thereto on February 23, 2026 to extend the outside date for completing the Arrangement contemplated therein (as so amended and restated, the “Arrangement Agreement”).”
Published 24 Feb 2026
Open the sourceWhat happened
HS North America Ltd. agreed to acquire Aptose, according to a filing dated Feb. 24, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
HS North America Ltd. agrees to buy Aptose
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Announced
“HS North America Ltd. agrees to buy Aptose HS North America Ltd. agreed to acquire Aptose, according to a filing dated Feb. 24, 2026”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly